Quarterly Report • Jan 24, 2011
Quarterly Report
Open in ViewerOpens in native device viewer
Q4 2010
"We finished a strong 2010 on a stable note with fourth-quarter EBITA of EUR 873 million, or 11.8 % of sales, bringing EBITA for the full year to a record 10%.
Revenue for the quarter came in at EUR 7.4 billion, a nominal increase of 2%. Comparable sales however declined by 4%, impacted by a weak Television market, negative consumer sentiment in developed markets and inventory management in the trade which resulted in a particularly slow December. Revenue in all three sectors was also negatively affected by fewer working days in the Philips reporting calendar.
On the positive side, we continued to see good mid-single-digit comparable sales growth at Home Healthcare Solutions and Patient Care & Clinical Informatics in Healthcare. Additionally, Healthcare orders grew 3% in the quarter, allowing order intake to grow 9% for the year, providing an excellent basis for sales growth in 2011. In Consumer Lifestyle, Personal Care and Health & Wellness posted strong high-singledigit growth. And in Lighting, Lumileds and LED-based lighting products and solutions continued their high double-digit growth rate.
For the full-year, sales, having rebounded strongly in the first half of the year, came in at EUR 25.4 billion, a 10% nominal increase from 2009. On a comparable basis, that represents growth of almost 4.5% for the year.
2010 was an eventful and overall positive year for Philips. We rebounded strongly from the economic downturn caused by the financial crisis. Within the constraints of an economy that remained weak, with fragile consumer confidence in most mature markets, we successfully implemented a major part of our Vision 2010 roadmap. Television profitability, however, remained a major issue that we are committed to resolve. We continued to strengthen our business portfolio and achieved an adjusted EBITA margin of 10.5%, significantly exceeding the target we had set ourselves three years ago. With that we set the stage for a successful future as outlined by our Vision 2015 program. Last but not least, we started to prepare for a seamless transition to a new leadership team.
Philips has undergone a profound transformation over the last decade. We are now a company with a clear focus, a customer-centric approach, a strong brand and a simpler structure. We are a global leader in important markets that are essential for tomorrow's world. We are a new Philips and we are ready for an even better future." Forward-looking statements
This document contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items, in particular the sections "Looking ahead" and "Outlook". Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future EBITA and future
developments in our organic business. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.
These factorsinclude but are not limited to domestic and global economic and business conditions, the successful implementation of our strategy and our ability to realize the benefits of this strategy, our ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, our ability to identify and complete successful acquisitions and to integrate those acquisitions into our business, our ability to successfully exit certain businesses or restructure our operations, the rate of technological changes, political, economic and other developments in countries where Philips operates, industry consolidation and competition. As a result, Philips' actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements. For a discussion of factors that could cause future results to differ from such forward-looking statements, see the Risk management chapter included in our Annual Report 2009 and the "Risk and uncertainties" section in our semi-annual financial report for the six months ended July 4, 2010.
Statements regarding market share, including those regarding Philips' competitive position, contained in this document are based on outside sources such as research institutes, industry and dealer panels in combination with management estimates. Where information is not yet available to Philips, those statements may also be based on estimates and projections prepared by outside sources or management. Rankings are based on sales unless otherwise stated.
In presenting and discussing the Philips Group's financial position, operating results and cash flows, management uses certain non-GAAP financial measures. These non-GAAP financial measures should not be viewed in isolation as alternatives to the equivalent IFRS measures and should be used in conjunction with the most directly comparable IFRS measures. A reconciliation of such measures to the most directly comparable IFRS measures is contained in this document. Further information on non-GAAP measures can be found in our Annual Report 2009.
In presenting the Philips Group's financial position, fair values are used for the measurement of various items in accordance with the applicable accounting standards. These fair values are based on market prices, where available, and are obtained from sources that are deemed to be reliable. Readers are cautioned that these values are subject to changes over time and are only valid at the balance sheet date. When quoted prices do not exist, we estimated the fair values using appropriate valuation models, and when observable market data are not available, we used unobservable inputs. They require management to make significant assumptions with respect to future developments, which are inherently uncertain and may therefore deviate from actual developments. Critical assumptions used are disclosed in our 2009 financial statements. Independent valuations may have been obtained to support management's determination of fair values.
All amounts in millions of euros unless otherwise stated; data included are unaudited. Financial reporting is in accordance with IFRS, unless otherwise stated. This document comprises regulated information within the meaning of the Dutch Financial Markets Supervision Act 'Wet op het Financieel Toezicht'.
in millions of euros unless otherwise stated
| Q4 | Q4 | |
|---|---|---|
| 2009 | 2010 | |
| Sales | 7,263 | 7,392 |
| EBITA | 662 | 873 |
| as a % of sales | 9.1 | 11.8 |
| EBIT | 555 | 755 |
| as a % of sales | 7.6 | 10.2 |
| Financial income and expenses |
(78) | (63) |
| Income taxes | (230) | (224) |
| Results investments in associates |
13 | (3) |
| Net income | 260 | 465 |
| Net income - shareholders per common share (in euros) - basic |
0.27 | 0.49 |
in millions of euros unless otherwise stated
| Q4 | Q4 | % change | ||
|---|---|---|---|---|
| 2009 | 2010 | nominal comparable | ||
| Healthcare | 2,405 | 2,642 | 10 | 2 |
| Consumer Lifestyle |
2,903 | 2,687 | (7) | (11) |
| Lighting | 1,846 | 1,975 | 7 | − |
| GM&S | 109 | 88 | (19) | (20) |
| Philips Group | 7,263 | 7,392 | 2 | (4) |
in millions of euros unless otherwise stated
| Q41) | Q4 | % change | ||
|---|---|---|---|---|
| 2009 | 2010 | nominal comparable | ||
| Western Europe | 2,804 | 2,540 | (9) | (10) |
| North America | 1,802 | 1,978 | 10 | 1 |
| Other mature markets | 421 | 462 | 10 | (4) |
| Total mature markets | 5,027 | 4,980 | (1) | (5) |
| Emerging markets | 2,236 | 2,412 | 8 | (1) |
| Philips Group | 7,263 | 7,392 | 2 | (4) |
1) Revised to reflect an adjusted market cluster allocation
• In the mature markets, improved business conditions in North America were more than offset by sales declines in Western Europe, primarily attributable to Consumer Lifestyle. Emerging markets saw a 1% comparable decline, as sales declined in key emerging markets, primarily attributable to operational issues in Brazil. Excluding Brazil, sales in emerging markets grew by 7%.
in millions of euros
| Q4 | Q4 | |
|---|---|---|
| 2009 | 2010 | |
| Healthcare | 452 | 522 |
| Consumer Lifestyle | 266 | 151 |
| Lighting | 82 | 198 |
| Group Management & | ||
| Services | (138) | 2 |
| Philips Group | 662 | 873 |
as a % of sales
| Q4 | Q4 | |
|---|---|---|
| 2009 | 2010 | |
| Healthcare | 18.8 | 19.8 |
| Consumer Lifestyle | 9.2 | 5.6 |
| Lighting | 4.4 | 10.0 |
| Group Management & Services |
(126.6) | 2.3 |
| Philips Group | 9.1 | 11.8 |
in millions of euros
| Q4 | Q4 | |
|---|---|---|
| 2009 | 2010 | |
| Healthcare | (27) | 4 |
| Consumer Lifestyle | (64) | (15) |
| Lighting | (103) | (34) |
| Group Management & Services |
(36) | (5) |
| Philips Group | (230) | (50) |
in millions of euros unless otherwise stated
| Q4 | Q4 | |
|---|---|---|
| 2009 | 2010 | |
| Healthcare | 392 | 459 |
| Consumer Lifestyle | 260 | 137 |
| Lighting | 41 | 156 |
| Group Management & Services |
(138) | 3 |
| Philips Group | 555 | 755 |
| as a % of sales | 7.6 | 10.2 |
| in millions of euros | ||
|---|---|---|
| Q4 | Q4 | |
| 2009 | 2010 | |
| Net interest expenses | (71) | (49) |
| Other | (7) | (14) |
| (78) | (63) |
| Q4 | Q4 | |
|---|---|---|
| 2009 | 2010 | |
| Beginning cash balance | 3,734 | 4,385 |
| Free cash flow | 726 | 1,336 |
| Net cash flow from operating activities | 935 | 1,558 |
| Net capital expenditures | (209) | (222) |
| Divestments (acquisitions) of businesses | 52 | (155) |
| Other cash flow from investing activities | 19 | 95 |
| Treasury shares transactions | 8 | 9 |
| Changes in debt/other | (153) | 163 |
| Ending cash balance | 4,386 | 5,833 |
in millions of euros
1) Capital expenditures on property, plant and equipment only
• Financial expenses were EUR 15 million lower than in Q4 2009, mainly due to EUR 22 million lower net interest expenses.
• Operating activities led to a cash inflow of EUR 1,558 million, which was EUR 623 million higher than in Q4 2009, driven by higher cash earnings and lower outflows from provisions, as well as last year's payment of the asbestos settlement.
• Gross capital expenditures on property, plant, and equipment were EUR 25 million higherthan in Q4 2009, mainly due to higher investment in LED equipment at Lighting.
as a % of moving annual total sales
Net debt and group equity (cash)
Number of employees
in FTEs
in millions of euros unless otherwise stated
| Q4 | Q4 | |
|---|---|---|
| 2009 | 2010 | |
| Sales | 2,405 | 2,642 |
| Sales growth | ||
| % nominal | (6) | 10 |
| % comparable | (1) | 2 |
| EBITA | 452 | 522 |
| as a % of sales | 18.8 | 19.8 |
| EBIT | 392 | 459 |
| as a % of sales | 16.3 | 17.4 |
| Net operating capital (NOC) | 8,434 | 8,908 |
| Number of employees (FTEs) | 34,296 | 35,479 |
EBITA
• Net operating capital increased by EUR 474 million to EUR 8.9 billion. Excluding a EUR 713 million currency impact, net operating capital decreased by EUR 239 million.
• In January 2011, Philips announced a strengthening of its leadership position in home healthcare with the acquisition of the main business of medSage Technologies LLC, a leading provider of patient interaction and management applicationsfor home care providers.
in millions of euros unless otherwise stated
| Q4 | Q4 | |
|---|---|---|
| 2009 | 2010 | |
| Sales | 2,903 | 2,687 |
| of which Television | 1,085 | 906 |
| Sales growth | ||
| % nominal | (3) | (7) |
| % comparable | 1 | (11) |
| Sales growth excl. Television | ||
| % nominal | (2) | (2) |
| % comparable | (3) | (6) |
| EBITA | 266 | 151 |
| of which Television | 29 | (67) |
| as a % of sales | 9.2 | 5.6 |
| EBIT | 260 | 137 |
| of which Television | 29 | (69) |
| as a % of sales | 9.0 | 5.1 |
| Net operating capital (NOC) | 625 | 911 |
| of which Television | (386) | (299) |
| Number of employees (FTEs) | 18,389 | 17,706 |
| of which Television | 4,766 | 3,613 |
in millions of euros
3,750
EBITA
in millions of euros unless otherwise stated
| Q4 | Q4 | |
|---|---|---|
| 2009 | 2010 | |
| Sales | 1,846 | 1,975 |
| Sales growth | ||
| % nominal | (5) | 7 |
| % comparable | − | − |
| EBITA | 82 | 198 |
| as a % of sales | 4.4 | 10.0 |
| EBIT | 41 | 156 |
| as a % of sales | 2.2 | 7.9 |
| Net operating capital (NOC) | 5,104 | 5,561 |
| Number of employees (FTEs) | 51,653 | 53,888 |
Sales in millions of euros
EBITA
• In January 2011, Philips has acquired North Americabased Optimum Lighting LLC, a company specialized in customized energy-efficient lighting solutions for the office, industry and retail segments. This acquisition strengthens our global leadership position in professional luminaires.
in millions of euros unless otherwise stated
| Q4 | Q4 | |
|---|---|---|
| 2009 | 2010 | |
| Sales | 109 | 88 |
| Sales growth | ||
| % nominal | (14) | (19) |
| % comparable | (11) | (20) |
| EBITA Corporate Technologies | (34) | (25) |
| EBITA Corporate & Regional Costs | (65) | (44) |
| EBITA Pensions | 51 | 91 |
| EBITA Service Units and Other | (90) | (20) |
| EBITA | (138) | 2 |
| EBIT | (138) | 3 |
| Net operating capital (NOC) | (1,514) | (3,309) |
| Number of employees (FTEs) | 11,586 | 11,928 |
in millions of euros
EBITA
in millions of euros
2011 will be a year of progress on the way to achieving our Vision 2015 objectives. Our strong order book provides confidence in our Healthcare business for the year ahead. We see the first leading indicators of positive momentum in construction markets, which is expected to benefit Lighting sales in the latter half of 2011, supported by the increased adoption of LED products. We expect emerging markets to continue to support growth in all three sectors while consumer sentiment in mature marketsremainssubdued. We will continue ourinitiatives to ignite growth in Consumer Lifestyle.
Amsterdam, January 24, 2011 Board of Management
in millions of euros unless otherwise stated
| January-December | ||
|---|---|---|
| 2009 | 2010 | |
| Sales | 23,189 | 25,419 |
| Sales growth | ||
| % nominal | (12) | 10 |
| % comparable | (11) | 4 |
| EBITA | 1,050 | 2,552 |
| as a % of sales | 4.5 | 10.0 |
| EBIT | 614 | 2,065 |
| as a % of sales | 2.6 | 8.1 |
| Financial income and expenses | (166) | (122) |
| Income taxes | (100) | (509) |
| Results investments in associates | 76 | 18 |
| Net income | 424 | 1,452 |
| Net income - shareholders per common share (in euros) - basic |
0.44 | 1.54 |
A proposal will be submitted to the General Meeting of Shareholders to pay a dividend of EUR 0.75 per common share (up to EUR 710 million), in cash or shares at the option of the shareholder, against the net income for 2010. Further details will be given in the agenda for the General Meeting of Shareholders, which will be published on February 17, 2011.
all amounts in millions of euros unless otherwise stated
| 4th quarter | January to December | |||
|---|---|---|---|---|
| 2009 | 2010 | 2009 | 2010 | |
| Sales | 7,263 | 7,392 | 23,189 | 25,419 |
| Cost of sales | (4,555) | (4,640) | (15,110) | (15,873) |
| Gross margin | 2,708 | 2,752 | 8,079 | 9,546 |
| Selling expenses | (1,495) | (1,470) | (5,159) | (5,246) |
| General and administrative expenses | (200) | (146) | (734) | (735) |
| Research and development expenses | (468) | (411) | (1,631) | (1,576) |
| Other business income | 24 | 44 | 97 | 100 |
| Other business expenses | (14) | (14) | (38) | (24) |
| Income from operations | 555 | 755 | 614 | 2,065 |
| Financial income | 17 | 13 | 225 | 214 |
| Financial expenses | (95) | (76) | (391) | (336) |
| Income before taxes | 477 | 692 | 448 | 1,943 |
| Income taxes | (230) | (224) | (100) | (509) |
| Income after taxes | 247 | 468 | 348 | 1,434 |
| Results relating to investments in associates | 13 | (3) | 76 | 18 |
| Net income | 260 | 465 | 424 | 1,452 |
| Attribution of net income | ||||
| Net income attributable to shareholders | 251 | 463 | 410 | 1,446 |
| Net income attributable to non-controlling interests | 9 | 2 | 14 | 6 |
| Weighted average number of common shares outstanding (after deduction of treasury shares) during the period (in thousands): |
||||
| - basic | 926,922 | 946,284 | 925,481 | 939,861 |
| - diluted | 933,261 | 952,937 | 929,037 | 947,725 |
| Net income attributable to shareholders | ||||
| per common share in euros: | ||||
| - basic | 0.27 | 0.49 | 0.44 | 1.54 |
| - diluted | 0.27 | 0.49 | 0.44 | 1.53 |
| Ratios | ||||
| Gross margin as a % of sales | 37.3 | 37.2 | 34.8 | 37.6 |
| Selling expenses as a % of sales | (20.6) | (19.9) | (22.2) | (20.6) |
| G&A expenses as a % of sales | (2.8) | (2.0) | (3.2) | (2.9) |
| R&D expenses as a % of sales | (6.4) | (5.6) | (7.0) | (6.2) |
| EBIT | 555 | 755 | 614 | 2,065 |
| as a % of sales | 7.6 | 10.2 | 2.6 | 8.1 |
| EBITA | 662 | 873 | 1,050 | 2,552 |
| as a % of sales | 9.1 | 11.8 | 4.5 | 10.0 |
in millions of euros unless otherwise stated
| December 31, 2009 | December 31, 2010 | |
|---|---|---|
| Non-current assets: | ||
| Property, plant and equipment | 3,252 | 3,265 |
| Goodwill | 7,362 | 8,035 |
| Intangible assets excluding goodwill | 4,161 | 4,198 |
| Non-current receivables | 85 | 88 |
| Investments in associates | 281 | 181 |
| Other non-current financial assets | 691 | 479 |
| Deferred tax assets | 1,243 | 1,351 |
| Other non-current assets | 1,543 | 75 |
| Total non-current assets | 18,618 | 17,672 |
| Current assets: | ||
| Inventories | 2,913 | 3,865 |
| Other current financial assets | 191 | 5 |
| Other current assets | 334 | 348 |
| Derivative financial assets | 102 | 112 |
| Income tax receivable | 81 | 79 |
| Receivables | 3,902 | 4,355 |
| Cash and cash equivalents | 4,386 | 5,833 |
| Total current assets | 11,909 | 14,597 |
| Total assets | 30,527 | 32,269 |
| Shareholders' equity | 14,595 | 15,046 |
| Non-controlling interests | 49 | 46 |
| Group equity | 14,644 | 15,092 |
| Non-current liabilities: Long-term debt |
3,640 | 2,818 |
| Long-term provisions | 1,734 | 1,716 |
| Deferred tax liabilities | 530 | 171 |
| Other non-current liabilities | 1,929 | 1,714 |
| Total non-current liabilities | 7,833 | 6,419 |
| Current liabilities: | ||
| Short-term debt | 627 | 1,840 |
| Derivative financial liabilities | 276 | 564 |
| Income tax payable | 118 | 291 |
| Accounts and notes payable | 2,870 | 3,691 |
| Accrued liabilities | 2,740 | 2,995 |
| Short-term provisions | 716 | 623 |
| Other current liabilities | 703 | 754 |
| Total current liabilities | 8,050 | 10,758 |
| Total liabilities and group equity | 30,527 | 32,269 |
| Number of common shares outstanding (after deduction of treasury shares) at the end of period (in thousands) |
927,457 | 946,506 |
| Ratios | ||
| Shareholders' equity per common share in euros | 15.74 | 15.90 |
| Inventories as a % of sales | 12.6 | 15.2 |
| Net debt : group equity | (1):101 | (8):108 |
| Net operating capital | 12,649 | 12,071 |
| Employees at end of period | 115,924 | 119,001 |
all amounts in millions of euros
| 4th quarter | January to December | |||
|---|---|---|---|---|
| 2009 | 2010 | 2009 | 2010 | |
| Cash flows from operating activities: | ||||
| Net income | 260 | 465 | 424 | 1,452 |
| Adjustments to reconcile net income to net cash provided by (used for) operating activities: | ||||
| Depreciation and amortization | 429 | 381 | 1,469 | 1,422 |
| Impairment of other non-current financial assets and (reversal of) impairment of investments in associates | 6 | (1) | 2 | 5 |
| Net gain on sale of assets | (13) | (24) | (140) | (211) |
| (Income) loss from investments in associates | (12) | 3 | (23) | (18) |
| Dividends received from investments in associates | 1 | 5 | 35 | 19 |
| Dividends paid to non-controlling interests | (2) | (3) | (4) | (4) |
| Decrease in working capital: | 606 | 671 | 704 | 16 |
| Decrease (increase) in receivables and other current assets | 365 | (87) | 496 | (194) |
| Decrease (increase) in inventories | 540 | 367 | 687 | (705) |
| (Decrease) increase in accounts payable, accrued and other liabilities | (299) | 391 | (479) | 915 |
| Increase (decrease) in non-current receivables/other assets/other liabilities | 150 | 27 | (363) | (291) |
| Decrease in provisions | (513) | (64) | (612) | (237) |
| Other items | 23 | 98 | 53 | 3 |
| Net cash provided by operating activities | 935 | 1,558 | 1,545 | 2,156 |
| Cash flows from investing activities: | ||||
| Purchase of intangible assets | (30) | (36) | (96) | (80) |
| Expenditures on development assets | (59) | (62) | (188) | (219) |
| Capital expenditures on property, plant and equipment | (151) | (176) | (524) | (653) |
| Proceeds from disposals of property, plant and equipment | 31 | 52 | 126 | 129 |
| Cash from (to) derivatives and securities | (1) | 9 | (39) | (25) |
| Purchase of other non-current financial assets | − | − | (6) | (16) |
| Proceeds from other non-current financial assets | 20 | 86 | 718 | 268 |
| Purchase of businesses, net of cash acquired | (13) | (170) | (294) | (223) |
| Proceeds from sale of interests in businesses | 65 | 15 | 84 | 117 |
| Net cash used for investing activities | (138) | (282) | (219) | (702) |
| Cash flows from financing activities: | ||||
| (Decrease) increase in short-term debt | (148) | 119 | (201) | 143 |
| Principal payments on long-term debt | (16) | (21) | (51) | (79) |
| Proceeds from issuance of long-term debt | 12 | 26 | 312 | 71 |
| Treasury shares transactions | 8 | 9 | 29 | 65 |
| Dividend paid | − | − | (634) | (296) |
| Net cash provided by (used for) financing activities | (144) | 133 | (545) | (96) |
| Net increase (decrease) in cash and cash equivalents | 653 | 1,409 | 781 | 1,358 |
| Effect of change in exchange rates on cash positions | (1) | 39 | (15) | 89 |
| Cash and cash equivalents at beginning of period | 3,734 | 4,385 | 3,620 | 4,386 |
| Cash and cash equivalents at end of period | 4,386 | 5,833 | 4,386 | 5,833 |
| Ratio | ||||
| Cash flows before financing activities | 797 | 1,276 | 1,326 | 1,454 |
| Net cash paid during the period for | ||||
| Pensions | (107) | (132) | (422) | (474) |
| Interest | (32) | (10) | (244) | (226) |
| Income taxes | (25) | (13) | (197) | (206) |
For a number of reasons, principally the effects of translation differences, certain items do not correspond to the differences between the balance sheet amounts for the respective items.
in millions of euros
| January to December 2010 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| other reserves | ||||||||||||
| com mon shares |
capital in ex cess of par val ue |
re tained earn ings |
revalu ation re serve |
curren cy trans lation differen ces |
unrealized gain (loss) on availa ble-for sale finan cial assets |
changes in fair value of cash flow hedges |
total | treas ury shares at cost |
total share hold ers' equity |
non con trolling inter ests |
total equity |
|
| Balance as of December 31, 2009 | 194 | − | 15,947 | 102 | (591) | 120 | 10 | (461) | (1,187) | 14,595 | 49 | 14,644 |
| Net income | 1,446 | 1,446 | 6 | 1,452 | ||||||||
| Net current period change | (1,336) | (16) | 530 | 180 | (39) | 671 | (681) | (681) | ||||
| Reclassifications into income | (4) | (161) | 24 | (141) | (141) | (141) | ||||||
| Total comprehensive income | 110 | (16) | 526 | 19 | (15) | 530 | 624 | 6 | 630 | |||
| Dividend distributed | 3 | 343 | (650) | (304) | (304) | |||||||
| Movement non-controlling interests | (9) | (9) | ||||||||||
| Re-issuance of treasury shares | (49) | 9 | 111 | 71 | 71 | |||||||
| Share-based compensation plans | 55 | 55 | 55 | |||||||||
| Income tax share-based compensation plans |
5 | 5 | 5 | |||||||||
| 3 | 354 | (641) | 111 | (173) | (9) | (182) | ||||||
| Balance as of December 31, 2010 | 197 | 354 | 15,416 | 86 | (65) | 139 | (5) | 69 | (1,076) | 15,046 | 46 | 15,092 |
all amounts in millions of euros unless otherwise stated
| 4th quarter | |||||||
|---|---|---|---|---|---|---|---|
| 2009 | |||||||
| sales | income from operations | sales | income from operations | ||||
| amount | as a % of sales | amount | as a % of sales | ||||
| Healthcare | 2,405 | 392 | 16.3 | 2,642 | 459 | 17.4 | |
| Consumer Lifestyle* | 2,903 | 260 | 9.0 | 2,687 | 137 | 5.1 | |
| Lighting | 1,846 | 41 | 2.2 | 1,975 | 156 | 7.9 | |
| Group Management & Services | 109 | (138) | (126.6) | 88 | 3 | 3.4 | |
| 7,263 | 555 | 7.6 | 7,392 | 755 | 10.2 | ||
| * of which Television | 1,085 | 29 | 2.7 | 906 | (69) | (7.6) | |
| January to December | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2009 | ||||||||
| sales | income from operations | sales | income from operations | |||||
| amount | as a % of sales | amount | as a % of sales | |||||
| Healthcare | 7,839 | 591 | 7.5 | 8,601 | 922 | 10.7 | ||
| Consumer Lifestyle* | 8,467 | 321 | 3.8 | 8,906 | 595 | 6.7 | ||
| Lighting | 6,546 | (16) | (0.2) | 7,552 | 695 | 9.2 | ||
| Group Management & Services | 337 | (282) | (83.7) | 360 | (147) | (40.8) | ||
| 23,189 | 614 | 2.6 | 25,419 | 2,065 | 8.1 | |||
| * of which Television | 3,122 | (179) | (5.7) | 3,155 | (130) | (4.1) |
in millions of euros
| total assets | ||||
|---|---|---|---|---|
| January to December | December 31, | December 31, | ||
| 2009 | 2010 | 2009 | 2010 | |
| Healthcare | 7,839 | 8,601 | 10,969 | 11,962 |
| Consumer Lifestyle* | 8,467 | 8,906 | 3,286 | 3,858 |
| Lighting | 6,546 | 7,552 | 6,748 | 7,379 |
| Group Management & Services | 337 | 360 | 9,524 | 9,070 |
| 23,189 | 25,419 | 30,527 | 32,269 | |
| * of which Television | 3,122 | 3,155 | 599 | 892 |
| sales | tangible and intangible assets1) | ||||
|---|---|---|---|---|---|
| January to December | December 31, | December 31, | |||
| 20092) | 2010 | 20092) | 2010 | ||
| Netherlands | 872 | 816 | 1,194 | 1,274 | |
| United States | 6,130 | 6,459 | 9,513 | 10,032 | |
| Germany | 1,969 | 2,003 | 288 | 282 | |
| China | 1,715 | 1,976 | 369 | 446 | |
| France | 1,501 | 1,457 | 111 | 100 | |
| Brazil | 936 | 1,092 | 128 | 148 | |
| Japan | 678 | 862 | 489 | 568 | |
| Other countries | 9,388 | 10,754 | 2,683 | 2,648 | |
| 23,189 | 25,419 | 14,775 | 15,498 |
1) Includes property, plant and equipment, intangible assets excluding goodwill, and goodwill
2) Revised to reflect an adjusted country allocation
in millions of euros
| 4th quarter | ||||||
|---|---|---|---|---|---|---|
| 2009 | 2010 | |||||
| Netherlands | other | total | Netherlands | other | total | |
| Costs of defined-benefit plans (pensions) | ||||||
| Service cost | 27 | 14 | 41 | 23 | 18 | 41 |
| Interest cost on the defined-benefit obligation | 133 | 99 | 232 | 130 | 105 | 235 |
| Expected return on plan assets | (189) | (87) | (276) | (186) | (86) | (272) |
| Curtailment | − | (5) | (5) | − | (1) | (1) |
| Settlement | − | − | − | − | (6) | (6) |
| Prior service cost | − | (6) | (6) | − | (83) | (83) |
| Other | 2 | 1 | 3 | 1 | 1 | 2 |
| Net periodic cost (income) | (27) | 16 | (11) | (32) | (52) | (84) |
| Costs of defined-contribution plans | 2 | 22 | 24 | 1 | 26 | 27 |
| Costs of defined-benefit plans (retiree medical) | ||||||
| Service cost | − | 1 | 1 | − | 1 | 1 |
| Interest cost on the defined-benefit obligation | − | 5 | 5 | − | 5 | 5 |
| Prior service cost | − | (1) | (1) | − | − | − |
| Curtailment | − | (47) | (47) | − | (9) | (9) |
| Other | − | 1 | 1 | − | − | − |
| Net periodic cost | − | (41) | (41) | − | (3) | (3) |
| January to December | ||||||
|---|---|---|---|---|---|---|
| 2009 | 2010 | |||||
| Netherlands | other | total | Netherlands | other | total | |
| Costs of defined-benefit plans (pensions) | ||||||
| Service cost | 107 | 75 | 182 | 92 | 77 | 169 |
| Interest cost on the defined-benefit obligation | 532 | 395 | 927 | 521 | 418 | 939 |
| Expected return on plan assets | (758) | (343) | (1,101) | (743) | (344) | (1,087) |
| Curtailment | − | (5) | (5) | − | (1) | (1) |
| Settlement | − | − | − | − | (6) | (6) |
| Prior service cost | − | (3) | (3) | − | (119) | (119) |
| Other | 2 | 1 | 3 | 1 | 1 | 2 |
| Net periodic cost (income) | (117) | 120 | 3 | (129) | 26 | (103) |
| Costs of defined-contribution plans | 8 | 99 | 107 | 7 | 111 | 118 |
| Costs of defined-benefit plans (retiree medical) | ||||||
| Service cost | − | 2 | 2 | − | 2 | 2 |
| Interest cost on the defined-benefit obligation | − | 32 | 32 | − | 20 | 20 |
| Prior service cost | − | (1) | (1) | − | (2) | (2) |
| Curtailment | − | (134) | (134) | − | (9) | (9) |
| Other | − | 1 | 1 | − | − | − |
| Net periodic cost | − | (100) | (100) | − | 11 | 11 |
all amounts in millions of euros unless otherwise stated.
Certain non-GAAP financial measures are presented when discussing the Philips Group's performance. In the following tables, a reconciliation to the most directly comparable IFRS performance measure is made.
| January to December | ||||||||
|---|---|---|---|---|---|---|---|---|
| comparable growth |
currency effects |
consolid ation changes |
nominal growth |
comparable growth |
currency effects |
consolid ation changes |
nominal growth |
|
| 2010 versus 2009 | ||||||||
| Healthcare | 1.5 | 8.7 | (0.3) | 9.9 | 3.9 | 6.0 | (0.2) | 9.7 |
| Consumer Lifestyle | (10.9) | 4.4 | (0.9) | (7.4) | 1.2 | 4.7 | (0.7) | 5.2 |
| Lighting | (0.3) | 6.9 | 0.4 | 7.0 | 8.7 | 6.0 | 0.7 | 15.4 |
| GM&S | (20.4) | 1.1 | − | (19.3) | 6.4 | 3.0 | (2.6) | 6.8 |
| Philips Group | (4.1) | 6.3 | (0.4) | 1.8 | 4.3 | 5.5 | (0.2) | 9.6 |
| Lighting GM&S |
|---|
| 869 (142) |
| (174) (5) |
| 695 (147) |
| 145 (282) |
| (161) − |
| (16) (282) |
1) Excluding amortization of software and product development
| December 31, | December 31, | |
|---|---|---|
| 2009 | 2010 | |
| Long-term debt | 3,640 | 2,818 |
| Short-term debt | 627 | 1,840 |
| Total debt | 4,267 | 4,658 |
| Cash and cash equivalents | 4,386 | 5,833 |
| Net debt (cash) (total debt less cash and cash equivalents) | (119) | (1,175) |
| Shareholders' equity | 14,595 | 15,046 |
| Non-controlling interests | 49 | 46 |
| Group equity | 14,644 | 15,092 |
| Net debt and group equity | 14,525 | 13,917 |
| Net debt divided by net debt and group equity (in %) | (1) | (8) |
| Group equity divided by net debt and group equity (in %) | 101 | 108 |
all amounts in millions of euros
| Philips Group | Healthcare | Consumer Lifestyle |
Lighting | GM&S | |
|---|---|---|---|---|---|
| December 31, 2010 | |||||
| Net operating capital (NOC) | 12,071 | 8,908 | 911 | 5,561 | (3,309) |
| Exclude liabilities comprised in NOC: | |||||
| - payables/liabilities |
10,009 | 2,603 | 2,509 | 1,485 | 3,412 |
| - intercompany accounts |
− | 54 | 95 | 68 | (217) |
| - provisions |
2,339 | 321 | 342 | 247 | 1,429 |
| Include assets not comprised in NOC: | |||||
| - investments in associates |
181 | 76 | 1 | 18 | 86 |
| - other current financial assets |
6 | − | − | − | 6 |
| - other non-current financial assets |
479 | − | − | − | 479 |
| - deferred tax assets |
1,351 | − | − | − | 1,351 |
| - cash and cash equivalents |
5,833 | − | − | − | 5,833 |
| Total assets | 32,269 | 11,962 | 3,858 | 7,379 | 9,070 |
| December 31, 2009 | |||||
| Net operating capital (NOC) | 12,649 | 8,434 | 625 | 5,104 | (1,514) |
| Exclude liabilities comprised in NOC: | |||||
| - payables/liabilities |
8,636 | 2,115 | 2,155 | 1,247 | 3,119 |
| - intercompany accounts |
− | 32 | 85 | 62 | (179) |
| - provisions |
2,450 | 317 | 420 | 324 | 1,389 |
| Include assets not comprised in NOC: | |||||
| - investments in associates |
281 | 71 | 1 | 11 | 198 |
| - other current financial assets |
191 | − | − | − | 191 |
| - other non-current financial assets |
691 | − | − | − | 691 |
| - deferred tax assets |
1,243 | − | − | − | 1,243 |
| - cash and cash equivalents |
4,386 | − | − | − | 4,386 |
| Total assets | 30,527 | 10,969 | 3,286 | 6,748 | 9,524 |
all amounts in millions of euros
| 4th quarter | January to December | |||
|---|---|---|---|---|
| 2009 | 2010 | 2009 | 2010 | |
| Cash flows provided by operating activities | 935 | 1,558 | 1,545 | 2,156 |
| Cash flows used for investing activities | (138) | (282) | (219) | (702) |
| Cash flows before financing activities | 797 | 1,276 | 1,326 | 1,454 |
| Cash flows provided by operating activities | 935 | 1,558 | 1,545 | 2,156 |
| Purchase of intangible assets | (30) | (36) | (96) | (80) |
| Expenditures on development assets | (59) | (62) | (188) | (219) |
| Capital expenditures on property, plant and equipment | (151) | (176) | (524) | (653) |
| Proceeds from property, plant and equipment | 31 | 52 | 126 | 129 |
| Net capital expenditures | (209) | (222) | (682) | (823) |
| Free cash flows | 726 | 1,336 | 863 | 1,333 |
all amounts in millions of euros unless otherwise stated
| 2009 | 2010 | |||||||
|---|---|---|---|---|---|---|---|---|
| 1st quarter |
2nd quarter |
3rd quarter |
4th quarter |
1st quarter |
2nd quarter |
3rd quarter |
4th quarter |
|
| Sales | 5,075 | 5,230 | 5,621 | 7,263 | 5,677 | 6,191 | 6,159 | 7,392 |
| % increase | (15) | (19) | (11) | (5) | 12 | 18 | 10 | 2 |
| EBITA | (74) | 118 | 344 | 662 | 504 | 527 | 648 | 873 |
| as a % of sales | (1.5) | 2.3 | 6.1 | 9.1 | 8.9 | 8.5 | 10.5 | 11.8 |
| EBIT | (186) | 8 | 237 | 555 | 389 | 404 | 517 | 755 |
| as a % of sales | (3.7) | 0.2 | 4.2 | 7.6 | 6.9 | 6.5 | 8.4 | 10.2 |
| Net income (loss) | (57) | 45 | 176 | 260 | 201 | 262 | 524 | 465 |
| Net income (loss) - shareholders per common share in euros - basic |
(0.06) | 0.05 | 0.19 | 0.27 | 0.22 | 0.28 | 0.55 | 0.49 |
| January March |
January June |
January September |
January December |
January March |
January June |
January September |
January December |
|
| Sales | 5,075 | 10,305 | 15,926 | 23,189 | 5,677 | 11,868 | 18,027 | 25,419 |
| % increase | (15) | (17) | (15) | (12) | 12 | 15 | 13 | 10 |
| EBITA | (74) | 44 | 388 | 1,050 | 504 | 1,031 | 1,679 | 2,552 |
| as a % of sales | (1.5) | 0.4 | 2.4 | 4.5 | 8.9 | 8.7 | 9.3 | 10.0 |
| EBIT | (186) | (178) | 59 | 614 | 389 | 793 | 1,310 | 2,065 |
| as a % of sales | (3.7) | (1.7) | 0.4 | 2.6 | 6.9 | 6.7 | 7.3 | 8.1 |
| Net income (loss) | (57) | (12) | 164 | 424 | 201 | 463 | 987 | 1,452 |
| Net income (loss) - shareholders per common share in euros - basic |
(0.06) | (0.02) | 0.17 | 0.44 | 0.22 | 0.49 | 1.05 | 1.54 |
| Net income (loss) from continuing operations as a % of shareholders' equity |
(1.6) | (0.2) | 1.5 | 2.7 | 5.9 | 6.7 | 9.3 | 9.6 |
| period ended 2009 | period ended 2010 | |||||||
| Inventories as a % of sales | 13.6 | 13.7 | 14.5 | 12.6 | 13.9 | 15.9 | 16.4 | 15.2 |
| Net debt : group equity ratio | 3:97 | 6:94 | 4:96 | (1):101 | 1:99 | 2:98 | 1:99 | (8):108 |
| Total employees (in thousands) | 116 | 116 | 118 | 116 | 116 | 117 | 118 | 119 |
Information also available on Internet, address: www.philips.com/investorrelations
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.